REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 23rd, 2022 • Freeline Therapeutics Holdings PLC • Biological products, (no disgnostic substances) • Illinois
REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of March 18, 2022, by and between FREELINE THERAPEUTICS HOLDINGS PLC, a public limited company incorporated under the laws of England and Wales (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (together with its permitted assigns, the “Investor”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).
PURCHASE AGREEMENTPurchase Agreement • March 23rd, 2022 • Freeline Therapeutics Holdings PLC • Biological products, (no disgnostic substances) • Illinois
THIS PURCHASE AGREEMENT (the “Agreement”), dated as of March 18, 2022, is made by and between FREELINE THERAPEUTICS HOLDINGS PLC, a public limited company incorporated under the laws of England and Wales (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (the “Investor”).
